MPPE1 and neoplasm: ScRNA sequencing study unveiled that caerin 1.1/1.9 administration significantly changes the tumour microenvironment (TME)38,39 recruiting and activating immune cells, such as T cells, NK cells and professional antigen presenting cells to the tumour, specifically, recruiting cDC1 dendritic cells to the tumour, even to the distant tumour site32.